LGND
Price
$184.98
Change
+$1.68 (+0.92%)
Updated
Oct 16, 12:01 PM (EDT)
Capitalization
3.57B
20 days until earnings call
Intraday Buy/Sell Signals
VKTX
Price
$35.16
Change
+$0.04 (+0.11%)
Updated
Oct 16, 12:25 PM (EDT)
Capitalization
3.95B
6 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

LGND vs VKTX

Header iconLGND vs VKTX Comparison
Open Charts LGND vs VKTXBanner chart's image
Ligand Pharmaceuticals
Price$184.98
Change+$1.68 (+0.92%)
Volume$100
Capitalization3.57B
Viking Therapeutics
Price$35.16
Change+$0.04 (+0.11%)
Volume$5.87K
Capitalization3.95B
LGND vs VKTX Comparison Chart in %
LGND
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VKTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LGND vs. VKTX commentary
Oct 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LGND is a Hold and VKTX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 16, 2025
Stock price -- (LGND: $183.30 vs. VKTX: $35.12)
Brand notoriety: LGND and VKTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LGND: 45% vs. VKTX: 74%
Market capitalization -- LGND: $3.57B vs. VKTX: $3.95B
LGND [@Biotechnology] is valued at $3.57B. VKTX’s [@Biotechnology] market capitalization is $3.95B. The market cap for tickers in the [@Biotechnology] industry ranges from $104.58B to $0. The average market capitalization across the [@Biotechnology] industry is $2.05B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LGND’s FA Score shows that 1 FA rating(s) are green whileVKTX’s FA Score has 0 green FA rating(s).

  • LGND’s FA Score: 1 green, 4 red.
  • VKTX’s FA Score: 0 green, 5 red.
According to our system of comparison, both LGND and VKTX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LGND’s TA Score shows that 3 TA indicator(s) are bullish while VKTX’s TA Score has 6 bullish TA indicator(s).

  • LGND’s TA Score: 3 bullish, 5 bearish.
  • VKTX’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, VKTX is a better buy in the short-term than LGND.

Price Growth

LGND (@Biotechnology) experienced а -0.65% price change this week, while VKTX (@Biotechnology) price change was +8.50% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.69%. For the same industry, the average monthly price growth was +16.97%, and the average quarterly price growth was +82.33%.

Reported Earning Dates

LGND is expected to report earnings on Nov 05, 2025.

VKTX is expected to report earnings on Oct 22, 2025.

Industries' Descriptions

@Biotechnology (-0.69% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VKTX($3.95B) has a higher market cap than LGND($3.57B). LGND YTD gains are higher at: 71.069 vs. VKTX (-12.724). LGND has higher annual earnings (EBITDA): -45.94M vs. VKTX (-212.42M). VKTX has more cash in the bank: 808M vs. LGND (255M). VKTX has less debt than LGND: VKTX (878K) vs LGND (5.74M). LGND has higher revenues than VKTX: LGND (188M) vs VKTX (0).
LGNDVKTXLGND / VKTX
Capitalization3.57B3.95B90%
EBITDA-45.94M-212.42M22%
Gain YTD71.069-12.724-559%
P/E Ratio46.19N/A-
Revenue188M0-
Total Cash255M808M32%
Total Debt5.74M878K654%
FUNDAMENTALS RATINGS
LGND vs VKTX: Fundamental Ratings
LGND
VKTX
OUTLOOK RATING
1..100
2120
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
35
Fair valued
PROFIT vs RISK RATING
1..100
3372
SMR RATING
1..100
9595
PRICE GROWTH RATING
1..100
3944
P/E GROWTH RATING
1..100
91100
SEASONALITY SCORE
1..100
7550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VKTX's Valuation (35) in the Biotechnology industry is somewhat better than the same rating for LGND (81). This means that VKTX’s stock grew somewhat faster than LGND’s over the last 12 months.

LGND's Profit vs Risk Rating (33) in the Biotechnology industry is somewhat better than the same rating for VKTX (72). This means that LGND’s stock grew somewhat faster than VKTX’s over the last 12 months.

LGND's SMR Rating (95) in the Biotechnology industry is in the same range as VKTX (95). This means that LGND’s stock grew similarly to VKTX’s over the last 12 months.

LGND's Price Growth Rating (39) in the Biotechnology industry is in the same range as VKTX (44). This means that LGND’s stock grew similarly to VKTX’s over the last 12 months.

LGND's P/E Growth Rating (91) in the Biotechnology industry is in the same range as VKTX (100). This means that LGND’s stock grew similarly to VKTX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
LGNDVKTX
RSI
ODDS (%)
Bearish Trend 2 days ago
71%
Bearish Trend 2 days ago
84%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
74%
Bearish Trend 2 days ago
73%
Momentum
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
85%
MACD
ODDS (%)
Bearish Trend 2 days ago
75%
Bullish Trend 2 days ago
81%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
72%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 8 days ago
82%
Declines
ODDS (%)
Bearish Trend 7 days ago
71%
Bearish Trend 30 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
89%
Aroon
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
LGND
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VKTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HRCAX121.53N/A
N/A
Harbor Capital Appreciation Admin
JORAX21.22N/A
N/A
Janus Henderson Global Select A
NCTWX33.14N/A
N/A
Nicholas II I
IRSEX15.82N/A
N/A
Macquarie Real Estate Securities R6
ISPVX20.42N/A
N/A
Macquarie Smid Cap Core Fund R6

LGND and

Correlation & Price change

A.I.dvisor indicates that over the last year, LGND has been loosely correlated with AGIO. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if LGND jumps, then AGIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LGND
1D Price
Change %
LGND100%
+1.32%
AGIO - LGND
49%
Loosely correlated
+2.83%
AXON - LGND
49%
Loosely correlated
-8.47%
CRSP - LGND
47%
Loosely correlated
+3.52%
ACLX - LGND
45%
Loosely correlated
+5.77%
OCUL - LGND
44%
Loosely correlated
+6.32%
More

VKTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, VKTX has been loosely correlated with NEVPF. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if VKTX jumps, then NEVPF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VKTX
1D Price
Change %
VKTX100%
+6.26%
NEVPF - VKTX
45%
Loosely correlated
N/A
GPCR - VKTX
41%
Loosely correlated
-2.92%
SYRE - VKTX
41%
Loosely correlated
+5.67%
TERN - VKTX
39%
Loosely correlated
+5.32%
IMTX - VKTX
39%
Loosely correlated
+6.59%
More